Cerner Collaborates with Florida Hospital and the Translational Research Institute for Metabolism and Diabetes to Streamline Research Processes

August 01, 2011

KANSAS CITY, Mo. and ORLANDO, Fla. — August 1, 2011 — Working to create an environment where translational research informatics systems reach into the patient care environment, Cerner Corporation (Nasdaq: CERN) is collaborating with Florida Hospital and the Florida Hospital - Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI) to create a streamlined research system that automates research activities and integrates them into the clinical care process.

This integration facilitates communication between the physicians and scientists treating patients and participants enrolled in clinical studies and the researchers responsible for study-specific care. This research system results in a safer, patient-centered environment that increases efficiency and provides improved data quality. The streamlined system has the potential to accelerate the discovery and development of new approaches to diagnose, prevent and treat disease.

“We’re facing an increasingly tight regulatory environment, so it makes sense for us to pursue innovative solutions to streamline and organize the clinical research environment. The Cerner®system allows us to emphasize both internal and external collaboration and create excellence in translational research,” said Steven R. Smith, MD, scientific director of the TRI. “The collaboration with Cerner creates an exciting opportunity for us to innovate, discover and ultimately cure metabolic diseases. Our goal is to have a major impact on the health of people living with diabetes and other metabolic diseases such as obesity and cardiovascular disease.”

Utilizing Cerner Millennium PowerTrials®, Florida Hospital will be able to eliminate the communication gap between research and clinical care departments seen in most traditional health care organizations. Florida Hospital will use the Cerner Millennium PowerTrials solution to connect TRI and other affiliated research institutes to clinical care by incorporating study screening and enrollment, tracking and data capture directly into the Cerner Millennium® electronic health record (EHR) system.

Using Cerner Discovere®, a Web-based research platform, will enable the TRI and other Florida Hospital research institutes to conduct collaborative research protocols within the Florida Hospital system, as well as with other clinical research sites. Using the Cerner Discovere platform will also allow TRI to connect with Florida Hospital’s Cerner Millennium EHR system, minimizing the need for manual data transfer and error-prone transcription.

“Our goal here is to lay a foundation of enabling research technologies that will facilitate pace-setting research,” said Duncan Grodack, director of research information systems with Florida Hospital. “We are the first in the nation to implement this system for our own studies, and we’re confident that it will help accelerate the speed of discovery in translational research.”

“Cerner provides the infrastructure for gaining new insights into health,” said Mark Hoffman, vice president of Cerner Research Solutions. “We are excited to work with our partners at Florida Hospital and TRI to demonstrate that connecting patient care and clinical research systems can speed progress along the path to recognizing those insights.”

Florida Hospital and the TRI plan to begin using the new system in late 2011, and expand into multiple protocols in 2012.

About Cerner

Cerner is transforming health care by eliminating error, variance and waste for health care providers and consumers around the world. Cerner® solutions optimize processes for health care organizations ranging in size from single-doctor practices, to health systems, to entire countries, for the pharmaceutical and medical device industries, employer health and wellness services industry and for the health care commerce system. These solutions are licensed by approximately 9,000 facilities around the world, including more than 2,600 hospitals; 3,500 physician practices covering more than 30,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; and 1,600 retail pharmacies. The trademarks, service marks and logos (collectively, the “Marks”) set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. Nasdaq: CERN. For more information about Cerner, please visit, Twitter, Facebook and YouTube.

Cerner Media Contact: Matt Dunn, (816) 446-1292,

Cerner Investors Contact: Allan Kells, (816) 201-2445,

About Florida Hospital

Florida Hospital is a faith based, full service, academic and teaching health care system focused on providing whole person care. It is one of the largest not-for-profit hospitals in the country caring for more than a million patient visits per year, and is part of the Adventist Health System of hospitals. The more than 2,100-bed system is comprised of eight hospitals locations throughout Central Florida. Florida Hospital is home to the largest diabetes and endocrine practice in Central Florida, as well as the Translational Research Institute for Metabolism and Diabetes. Florida Hospital is a designated statutory teaching hospital and also trains physicians from all around the world in the newest technologies. Florida Hospital has received the Joint Commission "Gold Seal" as well as the State of Florida "Governor's Sterling Award" for quality twice (1994 and 2010). For more information, please visit

Florida Hospital Media Contact:Sara Channing, 407-303-8213,

About the TRI

The Florida Hospital-Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI) is the product of an innovative affiliation between Florida Hospital and Sanford-Burnham Medical Research Institute. By linking one of the largest not-for-profit hospitals in the country with a nationally renowned basic science leader, the TRI bridges the gap between the research bench and the patient's bedside. The mission of the TRI is to extend and improve the quality of lives through the translation of fundamental scientific discoveries to the diagnosis and treatment of human disease.

The TRI's new 54,000-square-foot, technologically advanced translational research facility is currently under construction at Florida Hospital's Health Village in Orlando and is expected to open by the end of 2011. For additional information on the TRI, please visit or for The Sanford-Burnham Medical Research Institute, please visit

TRI Media Contact:Sara Channing, 407-303-8213,